Bevacizumab Reduces Adhesion Formation in Rats
Author Information
Author(s): Murat Basbug, Nurullah Bulbuller, Cemalettin Camci, Refik Ayten, Erhan Aygen, Ibrahim Hanifi Ozercan, Zulfu Arikanoglu, Sami Akbulut
Primary Institution: Firat University, Faculty of Medicine, Elazig, Turkey
Hypothesis
Can the angiogenesis inhibitor bevacizumab reduce peritoneal adhesions in a rat model?
Conclusion
Bevacizumab decreases adhesion formation following laparotomy in rats by blocking VEGF receptor occupancy.
Supporting Evidence
- The mean adhesion severity score in Group III was significantly lower than in Groups I and II.
- The fibrosis score in Group III was significantly less than in Groups I and II.
- VEGF staining in Group III was significantly lower than in Groups I and II.
Takeaway
This study found that a medicine called bevacizumab can help stop scars from forming inside the belly after surgery in rats.
Methodology
Thirty female Wistar albino rats were divided into three groups and underwent laparotomy with cecal wall abrasion; Group III received bevacizumab after the procedure.
Potential Biases
The researchers were blinded to the treatment groups, reducing bias.
Limitations
The study was conducted in a rat model, which may not fully replicate human physiology.
Participant Demographics
Thirty female Wistar albino rats, aged 11-12 weeks, weighing 200-224 g.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website